Eloxx Pharmaceuticals, Inc. of ARLINGTON, MA filed a DEF 14A with the SEC on 2022-10-31. Industry: Biological Products, (No Diagnostic Substances).
| Seq | Type | Description |
|---|---|---|
| 1 | DEF 14A | FORM DEF 14A |
| 2 | GRAPHIC | logo_eloxx.jpg |
| 3 | GRAPHIC | logo_eloxxx1.jpg |
| 4 | GRAPHIC | ny20005367x2-pc_1.jpg |
| 5 | GRAPHIC | ny20005367x2-pc_2.jpg |
| 6 | GRAPHIC | ny20005367x2_check.jpg |
| 7 | GRAPHIC | ny20005367x2_date.jpg |
| 8 | GRAPHIC | ny20005367x2_internet.jpg |
| 9 | GRAPHIC | ny20005367x2_location.jpg |
| 10 | GRAPHIC | ny20005367x2_mail.jpg |
| 11 | GRAPHIC | ny20005367x2_telephone.jpg |
| 12 | GRAPHIC | ny20005367x2_time.jpg |
| 13 | GRAPHIC | sig_saggarwal.jpg |
Showing 12 of 53 filings.
| Filed | Form |
|---|---|
| 2026-05-08 | DEF 14C |
| 2026-04-28 | PRE 14C |
| 2023-04-28 | DEFA14A |
| 2023-04-28 | DEF 14A |
| 2022-10-31 | DEF 14A |
| 2022-10-17 | PRE 14A |
| 2022-04-29 | DEFA14A |
| 2022-04-29 | DEF 14A |
| 2021-04-01 | DEFA14A |
| 2021-04-01 | DEF 14A |
| 2020-04-01 | DEFA14A |
| 2020-04-01 | DEF 14A |